I'm currently bullish on Novartis. Despite Goldman Sachs' warning, I think the recent rally is sustainable and the stock is positioned well with a nic...
Read
More
I'm currently bullish on Novartis. Despite Goldman Sachs' warning, I think the recent rally is sustainable and the stock is positioned well with a nice yield. I expect it to continue its upward trend, making it a solid choice for a swing trade.
Given the expected growth in the respiratory drugs market driven by increasing prevalence of respiratory disorders and Novartis' strong presence in th...
Read
More
Given the expected growth in the respiratory drugs market driven by increasing prevalence of respiratory disorders and Novartis' strong presence in this space, I anticipate a short-term uptick in NVS stock. A bullish play on NVS seems warranted.